Immunocore Holdings plc Inventory Writedown2011
Immunocore Holdings plc (IMCR) reported Inventory Writedown2011 of GBP 28.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-01.
Discontinued › Notes › Inventory
ifrs-full:InventoryWritedown2011 · last filed 2023-03-01
- Immunocore Holdings plc inventory writedown2011 for the quarter ending 2022-12-31 was -157.00K GBP.
| Period end | Inventory Writedown2011 3 month | Inventory Writedown2011 9 month | Inventory Writedown2011 12 month |
|---|---|---|---|
| 2022-12-31 | -157.00K GBP derived: 20-F 12 month − 6-K/A 9 month · filed 2023-03-01 | 28.00K GBP 20-F · filed 2023-03-01 | |
| 2022-09-30 | 185.00K GBP 6-K/A · filed 2022-11-18 | ||
| 2021-12-31 | 871.00K GBP 20-F · filed 2023-03-01 | ||
| 2020-12-31 | 0.00 GBP 20-F · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |